ORCA
Online Research @ CardiffÂ
Browse by All Cardiff Authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 7.
Binns, Alison M, Wood, Ashley  ORCID: https://orcid.org/0000-0002-9312-6184, Burns, Sarah, Ctori, Irene, Grewal, Manjot Kaur, Johnson, Sean, Lowe, Rachel, Nollett, Clare, Pattni, Krishna, Playle, Rebecca ORCID: https://orcid.org/0000-0002-2989-1092, Silva, Vera, Votruba, Marcela ORCID: https://orcid.org/0000-0002-7680-9135, Lee, Yunhee and Margrain, Tom H. ORCID: https://orcid.org/0000-0003-1280-0809
2026.
Oral glycoside supplement (triterpenoid saponins) for early and intermediate stage age-related macular degeneration (SAMADI trial): study protocol for a double masked randomised placebo-controlled feasibility trial.
Pilot and Feasibility Studies
10.1186/s40814-026-01888-6
|
|
|
|
Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441, Thomas, Abin ORCID: https://orcid.org/0000-0002-8283-6762, Hills, Robert K. ORCID: https://orcid.org/0000-0003-0166-0062, King, Sophie, Thomas, Ian, Marquez-Almuina, Nuria, Burns, Sarah, Gilkes, Amanda F., Irwin, Sarah, Sellar, Rob S., Green, Simone, Overgaard, Ulrik Malthe, Mehta, Priyanka, Dennis, Mike, Freeman, Sylvie D. and Russell, Nigel H.
2026.
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial.
Blood
10.1182/blood.2025032681
|
|
|
Russell, Nigel H., Thomas, Abin ORCID: https://orcid.org/0000-0002-8283-6762, Hills, Robert K., Thomas, Ian, Gilkes, Amanda, Marquez Almuina, Nuria, Burns, Sarah, Marsh, Lucy, Vyas, Paresh, Metzner, Marlen, McCarthy, Nicholas, Andrew, Georgia, Byrne, Jennifer, Sellar, Rob S., Kelly, Richard, Cahalin, Paul, Malthe Overgaard, Ulrik, Mehta, Priyanka, Dennis, Mike, Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441 and Freeman, Sylvie D.
2025.
Treatment intensification with either fludarabine, AraC, G-CSF and idarubicin, or cladribine plus daunorubicin and AraC on the basis of residual disease status in older patients With AML: Results From the NCRI AML18 Trial.
Journal of Clinical Oncology
43
(6)
, pp. 694-704.
10.1200/JCO.24.00259
|
|
|
|
Freeman, Sylvie D, Thomas, Abin, Thomas, Ian, Vyas, Paresh, Gilkes, Amanda, Metzner, Marlen, Jakobsen, Niels Asger, Kennedy, Alison, Moore, Amy, Marquez Almuina, Nuria, Burns, Sarah, King, Sophie, Andrew, Georgia M., Gallagher, Kathleen M.E., Sellar, Rob, Cahalin, Paul, Weber, Duruta, Dennis, Mike, Mehta, Priyanka, Knapper, Steve ORCID: https://orcid.org/0000-0002-6405-4441 and Russell, Nigel H.
2022.
A randomized comparison of the fractionated versus single dose schedule of Gemtuzumab Ozogamicin at induction with determinants of benefit for older AML patients: UK NCRI AML18 trial results.
Blood
140
(S1)
, pp. 532-533.
10.1182/blood-2022-162245
|
|
|
|
Burnett, Alan Kenneth, Russell, N. H., Hills, Robert Kerrin ORCID: https://orcid.org/0000-0003-0166-0062, Kell, J., Nielsen, O. J., Dennis, M., Cahalin, P., Pocock, C., Ali, S., Burns, Sarah, Freeman, S., Milligan, D. and Clark, R. E.
2017.
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia.
Leukemia
31
(2)
, pp. 310-317.
10.1038/leu.2016.225
|
|
|
|
Macbeth, Fergus R., Griffiths, Gareth O., Noble, Simon Ian Robert ORCID: https://orcid.org/0000-0001-5425-2383, Burns, Sarah and Maughan, Timothy Stanley
2009.
Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin® added to standard therapy in patients with lung cancer [Abstract].
Journal of Thoraric Oncology
4
(9)
, pp. S5-S968.
10.1097/JTO.0b013e3181b9c77e
|
|
|
|
Griffiths, Gareth O., Burns, Sarah, Noble, Simon Ian Robert ORCID: https://orcid.org/0000-0001-5425-2383, Macbeth, Fergus R, Cohen, David and Maughan, Timothy Stanley
2009.
Fragmatic: a randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer.
BMC Cancer
9
, pp. 355-363.
10.1186/1471-2407-9-355
|
|
|